Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Ann Rheum Dis. 2017 Oct 27;76(12):1955–1964. doi: 10.1136/annrheumdis-2017-211468

Table 1.

Demographic data of the International Myositis Classification Criteria Project cohort

IIM
(n=976)
Comparators
(n=624)

Sex, n (%)
 Female 652 (66.8) 369 (59.1)
 Male 324 (33.2) 255 (40.9)

Adult onset disease*, n (%) 727 (74.5) 509 (81.6)
Childhood onset disease*, n (%) 249 (25.5) 115 (18.4)

Age at onset of symptom, median (IQR), years 44.0 (14.7–57.0) 41.0 (20.0–56.0)

Age at diagnosis, median (IQR), years 45.5 (16.2–59.3) 45.0 (25.8–58.0)

Disease duration from time of first symptom, median (IQR), years 4.0 (2.0–8.0) 4.0 (1.0–9.0)

Disease duration from time of diagnosis, median (IQR), years 3.0 (1.0–6.0) 1.8 (0.0–4.5)

Ethnicity, n (%)
 Caucasian 611 (62.6) 360 (57.7)
 Asian 177 (18.1) 156 (25.0)
 Hispanic 51 (5.2) 25 (4.0)
 African 40 (4.1) 28 (4.5)
 Native American 18 (1.8) 4 (0.6)
 Pacific Island 3 (0.3) 1 (0.2)
 Mixed 37 (3.8) 22 (3.5)
 Unknown 54 (5.5) 32 (5.1)

Disease onset§, n (%)
 Acute (days to 2 weeks) 45 (4.6) 64 (10.3)
 Subacute (> 2 weeks to ≤ 2 months) 237 (24.3) 88 (14.1)
 Insidious (> 2 months to years) 648 (66.4) 444 (71.2)
 NA 46 (4.7) 28 (4.5)
*

Onset of first symptoms assumed to be related to the disease

Time from first symptom to last clinical evaluation

Time from diagnosis to last clinical evaluation

§

Onset and progression of the first symptoms of the syndrome to the full disease presentation

IIM, idiopathic inflammatory myopathies; IQR, interquartile range; NA, information not available